Internal Audit Focus on Requalification Evidence After Significant Changes Internal Audit Focus on Requalification Evidence After Significant Changes Introduction to Requalification After Equipment Change The pharmaceutical industry operates under strict regulatory frameworks established by governing bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA). One critical aspect of maintaining compliance is the requalification of equipment following significant changes. This article addresses the intricacies of requalification after equipment change, emphasizing the importance of documentation and systematic approaches during internal audits. Upon making significant modifications to equipment, organizations…

Global Expectations FDA EMA MHRA for Requalification and Change Control Global Expectations FDA EMA MHRA for Requalification and Change Control The process of requalification and change control is critical in maintaining compliance with regulatory standards set forth by authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA). The evolution of these regulatory expectations influences the pharmaceutical industry’s approach to equipment qualification, calibration management, and quality assurance. Understanding Requalification in the Context of Regulation Requalification refers to the systematic approach used to ensure that equipment, systems,…

How to handle requalification for relocated equipment and new sites How to Handle Requalification for Relocated Equipment and New Sites In the regulated environment of pharmaceutical and medical device manufacturing, compliance with various regulatory standards is critical. One of the requirements lies within the qualification of equipment, especially when changes occur such as relocation or installation at new sites. This article aims to present a comprehensive guide on handling requalification for relocated equipment and new sites, underscoring best practices for ensuring compliance with FDA, EMA, and MHRA regulations. This guideline will serve professionals involved in regulatory affairs, clinical operations, and…

Future of Requalification Continuous Verification and Adaptive Validation Future of Requalification Continuous Verification and Adaptive Validation The landscape of regulatory compliance in the pharmaceutical industry is continually evolving, particularly concerning the requalification of equipment and the overarching change control processes. As regulatory authorities aim to enhance efficiency while ensuring safety and effectiveness, the method of continuous verification and adaptive validation becomes paramount. This article will elucidate these concepts, particularly in the context of requalification after equipment change, risk-based requalification strategies, and adaptive validation methodologies. By managing change effectively and leveraging advanced strategies, organizations can align with FDA, EMA, and MHRA…

Governance for Approving Requalification Strategies at Site Level Governance for Approving Requalification Strategies at Site Level In the pharmaceutical and biopharmaceutical industries, the management of equipment qualifications is a critical component of ensuring product quality and compliance with regulatory standards. This comprehensive guide explores the governance frameworks necessary for approving requalification strategies at site level, with a focus on requalification after equipment change, risk-based approaches, and best practices aligned with FDA, EMA, and MHRA regulations. Understanding Equipment Qualification and Requalification Equipment qualification is a systematic process to ensure that equipment functions correctly and consistently produces results that meet predetermined specifications….

Linking Requalification Activity to CPV, Deviations and Product History Linking Requalification Activity to CPV, Deviations and Product History The integration of requalification activities into the lifecycle management of equipment is crucial for compliance with regulations set forth by the FDA, EMA, and MHRA. As the pharmaceutical industry evolves with new technologies and practices, understanding the impact of change control and the implications of deviations on qualification and requalification activities is pivotal for ensuring product quality and patient safety. This article serves as a comprehensive guide for pharma professionals, clinical operations, and regulatory affairs experts on how to effectively link requalification…

Examples of Strong Requalification Processes Highlighted in Inspections Examples of Strong Requalification Processes Highlighted in Inspections In the pharmaceutical and biopharmaceutical sectors, ensuring compliance with regulatory standards for equipment qualification is of paramount importance. Equipment qualification not only enriches product quality but also secures patient safety and compliance with the FDA, EMA, MHRA, and ICH guidelines. The significance of having an effective requalification process becomes evident during regulatory inspections, where the ability to demonstrate robust requalification practices can directly influence the outcome of audits and the continued operation of pharmaceutical firms. This article dives deep into the essential aspects of…

Requalification Planning to Minimise Downtime and Impact on Production Requalification Planning to Minimise Downtime and Impact on Production In the pharmaceutical industry, ensuring that equipment remains in compliance after changes such as relocation or upgrades is a critical process that demands a comprehensive understanding of regulatory frameworks. This article delves into the nuances of requalification planning after equipment changes, emphasizing regulatory expectations from authorities such as the FDA, EMA, and MHRA. Utilizing a risk-based requalification strategy can significantly minimize downtime and maintain production integrity, which is crucial for maintaining compliance and operational efficiency. Understanding Requalification After Equipment Change The requalification…

Training Teams on When to Ask for Requalification and Why It Matters Understanding Requalification Requirements: When and Why Teams Should Initiate the Process Introduction to Equipment Requalification In the pharmaceutical and biopharmaceutical landscapes, ensuring that equipment remains in a validated state throughout its operational life is paramount. Equipment requalification, particularly after any significant changes, is not just a regulatory requirement but a crucial element of maintaining compliance and product quality. This article aims to equip pharmaceutical professionals with the knowledge necessary to understand when and why to ask for requalification following equipment changes. It also highlights the significance of a…

Documenting Requalification Rationale in Validation and Change Records Documenting Requalification Rationale in Validation and Change Records In today’s highly regulated environment, the validation and qualification of equipment play a crucial role in ensuring the safety, efficacy, and quality of pharmaceutical products. As technology evolves, especially with the introduction of software upgrades and changes to equipment, a robust framework for documenting requalification rationale becomes essential. This article outlines the critical components of requalification after equipment change alongside best practices and regulatory expectations from the FDA, EMA, and MHRA. Understanding Requalification in the Context of Equipment Changes Requalification is a systematic approach…